Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001036050-01-500045
Filing Date
2001-03-28
Accepted
2001-03-28 00:00:00
Documents
4
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 VIROPHARMA, INC. FORM 10-K d10k.txt 10-K 230812
2 STATEMENT OF COMPUTATION OF LOSS PER SHARE dex11.txt EX-11 2311
3 SCHEDULE OF RATIO OF EARNINGS TO FIXED CHARGES dex121.txt EX-12.1 1815
4 CONSENT OF KPMG LLP dex23.txt EX-23 1081
  Complete submission text file 0001036050-01-500045.txt   237860
Mailing Address 76 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 405 EAGLEVIEW BLVD PO BOX 5000 EXTON PA 19341 6104587300
VIROPHARMA INC (Filer) CIK: 0000946840 (see all company filings)

EIN.: 232789550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21699 | Film No.: 1582405
SIC: 2834 Pharmaceutical Preparations